| 陈春燕,程纬民.程纬民教授基于壮医“毒虚致病”理论辨治原发性免疫性血小板减少症经验[J].中国医药导报,2024,21(6):147-150 |
二维码（扫一下试试看！） |
| 程纬民教授基于壮医“毒虚致病”理论辨治原发性免疫性血小板减少症经验 |
| Professor Cheng Weimin’s experience in treating primary immune thrombocytopenia based on the theory of “toxic deficiency causing disease” in Zhuang medicine |
| 收稿日期： 修订日期：2023-08-08 |
| DOI：10.20047/j.issn1673-7210.2024.06.34 |
| 关键词: 原发性免疫性血小板减少症 壮医 毒虚致病 治疗经验 |
| Key Words: |
| 基金项目:广西自然科学基金面上项目（2023GXNSFAA 026047、2018GXNSFAA281082） |
|
| 摘要点击次数: 715 |
| 全文下载次数: 242 |
| 摘要:原发性免疫性血小板减少症是以血小板减少为主要特征的疾病，现代医学针对原发性免疫性血小板减少症治疗是在不良反应最小化基础上提升患者血小板数量至安全水平，减少出血事件，但大多数患者常伴有乏力、焦虑等临床表现，影响患者的生活质量。“毒虚致病”源于壮医毒虚学说，毒与虚共同导致疾病发生，影响疾病的发展与转归。程纬民教授从壮医毒虚理论出发，认为原发性免疫性血小板减少症致病因素关键在于风、湿、火、热毒邪，气血阴阳虚损可加快疾病进展，治疗原则上主张祛毒邪兼以扶正，把握致病关键因素，加强利于阻断致病因素中药，防病传变。最后附验案两则，以期为临床治疗提供新参考。 |
| Abstract:Primary immune thrombocytopenia is a disease characterized by thrombocytopenia. The treatment of primary immune thrombocytopenia in modern medicine is to improve the number of platelets to a safe level and reduce bleeding events on the basis of minimizing adverse reactions. However, most patients are often accompanied by fatigue, anxiety, and other clinical manifestations, affecting the quality of life of patients. “Toxic deficiency causing disease” is derived from the theory of poison deficiency theory in Zhuang medicine，which believes that both toxin and deficiency lead to the occurrence of disease, and affect the development and outcome. Based on the theory of poison deficiency in Zhuang medicine, Professor Cheng Weimin believes that the key pathogenic factors of primary immune thrombocytopenia are wind, dampness, fire and heat toxin. The deficiency of qi, blood, yin and yang can accelerate the progression of the disease. In principle, the treatment advocates eliminating toxin and strengthening the body, grasping the key pathogenic factors, strengthening the traditional Chinese medicine that is conducive to blocking the pathogenic factors, and preventing disease transmission. Finally, two proven cases are attached in order to provide new reference for clinical treatment. |
| 查看全文 HTML 查看/发表评论 下载PDF阅读器 |
